{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:57:33Z","timestamp":1781351853989,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jgar.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:31:06Z","timestamp":1772926266000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between the blaZ gene and the cefazolin inoculum effect among bloodstream isolates of methicillin-susceptible Staphylococcus aureus"],"prefix":"10.1016","volume":"48","author":[{"given":"Wenyan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-2754","authenticated-orcid":false,"given":"Yanyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.02.012_bib0001","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac190","article-title":"Incidence of monomicrobial Staphylococcus aureus bacteremia: a population-based study in Olmsted County, Minnesota\u20142006 to 2020","volume":"9","author":"Hindy","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.012_bib0002","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jgar.2026.02.012_bib0003","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmi.2017.07.003","article-title":"Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review","volume":"24","author":"Loubet","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2026.02.012_bib0004","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/AAC.02800-14","article-title":"Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/phar.1892","article-title":"\u03b2-lactam therapy for methicillin-susceptible Staphylococcus aureus bacteremia: a comparative review of cefazolin versus antistaphylococcal penicillins","volume":"37","author":"Li","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2026.02.012_bib0006","doi-asserted-by":"crossref","first-page":"e02511","DOI":"10.1128\/AAC.02511-19","article-title":"Novel insights into the classification of staphylococcal \u03b2-lactamases in relation to the cefazolin inoculum effect","volume":"64","author":"Carvajal","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0007","series-title":"The Sanford Guide to Antimicrobial Therapy","author":"Gilbert","year":"2023"},{"key":"10.1016\/j.jgar.2026.02.012_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.51353","article-title":"\u03b2-lactam inoculum effect in methicillin-susceptible Staphylococcus aureus infective endocarditis","volume":"7","author":"Jean","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jgar.2026.02.012_bib0009","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/jac\/dkt254","article-title":"Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals","volume":"68","author":"Rinc\u00f3n","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0010","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2024"},{"key":"10.1016\/j.jgar.2026.02.012_bib0011","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00052-12","article-title":"Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","volume":"56","author":"Livorsi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116399","article-title":"Cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus clinical isolates","volume":"110","author":"Tsuji","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.012_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02495-21","article-title":"Prevalence and characterization of the cefazolin inoculum effect in North American methicillin-susceptible Staphylococcus aureus isolates","volume":"60","author":"Dingle","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2026.02.012_bib0014","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.42.12.3163","article-title":"Characterization of a chromosomal gene encoding type B \u03b2-lactamase in phage group II isolates of Staphylococcus aureus","volume":"42","author":"Voladri","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2-lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.jgar.2026.02.012_bib0016","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/jac\/dkz226","article-title":"Inoculum effect of \u03b2-lactam antibiotics","volume":"74","author":"Lenhard","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0017","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/AAC.00485-11","article-title":"Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0018","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/AAC.00052-12","article-title":"Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","volume":"56","author":"Livorsi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0019","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10096-016-2799-1","article-title":"Characteristics of cefazolin inoculum effect-positive methicillin-susceptible Staphylococcus aureus infection in a multicentre bacteraemia cohort","volume":"36","author":"Song","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.012_bib0020","doi-asserted-by":"crossref","first-page":"e00382","DOI":"10.1128\/AAC.00382-18","article-title":"Prevalence of a cefazolin inoculum effect associated with blaZ gene types among methicillin-susceptible Staphylococcus aureus isolates from four major medical centers in Chicago","volume":"62","author":"Wang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0021","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.07.011","article-title":"The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr)","volume":"83","author":"Wi","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.012_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/cix287","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"65","author":"McDanel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.012_bib0023","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jiph.2018.02.004","article-title":"Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia","volume":"11","author":"Monogue","year":"2018","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jgar.2026.02.012_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy123","article-title":"The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"5","author":"Miller","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.012_bib0025","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/AAC.00317-09","article-title":"Inoculum effect with Cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of Cefazolin treatment failure","volume":"53","author":"Nannini","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.02.012_bib0026","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jgar.2026.02.012_bib0027","doi-asserted-by":"crossref","first-page":"e01938","DOI":"10.1128\/JCM.01938-20","article-title":"A test for the rapid detection of the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus","volume":"59","author":"Rincon","year":"2021","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:27:14Z","timestamp":1781350034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"alternative-id":["S2213716526000299"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.02.012","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between the blaZ gene and the cefazolin inoculum effect among bloodstream isolates of methicillin-susceptible Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}